Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · Real-Time Price · USD
7.68
-0.32 (-4.00%)
At close: Dec 5, 2025, 4:00 PM EST
7.76
+0.08 (1.04%)
After-hours: Dec 5, 2025, 6:28 PM EST
Relay Therapeutics Market Cap
Relay Therapeutics has a market cap or net worth of $1.33 billion as of December 5, 2025. Its market cap has increased by 62.63% in one year.
Market Cap
1.33B
Enterprise Value
768.01M
1-Year Change
62.63%
Ranking
Category
Stock Price
$7.68
Market Cap Chart
Since July 16, 2020, Relay Therapeutics's market cap has decreased from $3.03B to $1.33B, a decrease of -56.14%. That is a compound annual growth rate of -14.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 1.39B | 101.06% |
| Dec 31, 2024 | 689.62M | -49.19% |
| Dec 29, 2023 | 1.36B | -24.86% |
| Dec 30, 2022 | 1.81B | -45.57% |
| Dec 31, 2021 | 3.32B | -11.11% |
| Dec 31, 2020 | 3.73B | 22.99% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 925.43B |
| Johnson & Johnson | 494.70B |
| AbbVie | 406.92B |
| UnitedHealth Group | 307.72B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 253.84B |
| Thermo Fisher Scientific | 218.08B |